Cambridge, MA · Founded 2015 · Privately Held (backing)
Developer of vascular-targeted biotherapeutics designed for the treatment of solid cancers and other diseases of pathological angiogenesis. Angiex is based in Cambridge, MA and was founded in 2015. Its last reported valuation was $183 million in Aug 2021. It has raised $98.7 million across 2 recorded rounds; the latest was a $22 million early-stage round in Jul 2025.
Last reported valuation
$182.6M
Oct 2026
Priced at
—
Total raised
$98.7M
Last round
Early Stage VC
Jul 2025
Team — not yet on record
No current team members for Angiex are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Angiex with a free account
·The complete investor list: 19 names
·Watch Angiex: the Monday email on marks, rounds and moves
